Polypharmacy and inappropriate drug prescribing in elderly nursing home residents;Polifarmacija in neprimerno predpisovanje zdravil pri starostnikih v domovih starejših obcanov

Zdravniski Vestnik

Volumn 78, Issue 5, 2009, Pages 231-240

  Šter, Marija Petek ^a   Gorup, Eva Cedilnik ^b   Klancic, Dean ^a  

^a Zdru enje zdravnikov dru inske medicine   (Slovenia)

^b Zdravstveni dom Domžale ^*  (Slovenia)

Author keywords

Beers criteria; Elderly people; Interactions; Nursing home; Polypharmacotherapy

Indexed keywords

EID: 77952395846     PISSN: 13180347     EISSN: 15810224     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Howard R, Avery T. Inappropriate prescribing in older people. Age and Ageing 2004; 33: 530-532
2. Field TS, Garwitz JH, Avorn J, McCormick DM, Shailavi J, Eckler M, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001; 161: 1629-1634
3. Tulner LR, Frankfort SV, Gijsen GJPT, van Campen JPCM, Koks HW, Beijnen JH. Drug-drug Interactions in a geriatric outpatient cohort. Drugs Aging 2008; 25: 343-355
4. Stevenson J, Abernethy AP, Miller C, Curoow DC. Managing comorbitidities in patients at the end of life. BMJ 2004; 329: 909-912
5. Fialova D, Topinkova E, Gambassi G, Finne Soveri H, Jonsson PV, Carpenter I et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348-1358
6. Lau DT, Kasper JD, Potter DEB, Lyles A, Bennet RG. Hospitalization and death associated with potentially inappropriate medication prescriptions amond elderly nursing home residents. Arch Intern Med 2005; 165: 68-74.
7. Raivio MM, Laurila JV, Strandber TE, Reijo ST, Kaisu HP. Use of Inappropriate Medications and their prognostic significance among in-hospital and nursing home patients with and without dementia in Finland. Drugs Aging 2008; 23: 333-343
8. Perri III M, Menon AM, Deshpande AD, Shinde SB, Jiank R, Cooper JW, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2006; 39: 405-411
9. Bergman A, Olsson J, Carlsten A, Waern M, Fastbom J. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 2007; 25: 9-14.
10. Mamun K, Lien CTC, Goh-Tan CYE, Ang WST. Polyphrmacy and inappropriate medication use in Singapore nursing homes. Ann Acad Med Singapore 2004; 33: 49-52.
11. M3 Project. Top ten Dangerous interactions in long term care. Dosegljivo na: http://www.scoup.net/M3project/topten/.
12. Zorman I, Posega A, Remškar J, Valcic Ž. Zdravstvena nega v socialnovarstvenih zavodih. Ucna delavnica. Zavod za zdravstveno zavarovanje Slovenije; Ljubljana 31. 3. 2004.
13. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean R, Beers MH. Updating Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716-2724
14. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading but manageable. Clinical Interventions in Aging 2008; 3: 383-389
15. Lawrenson R, Williams T. Farmer R. Clinical information for research the use of general practice databases. J Public Health Med 1999; 21: 299-304.
16. Gresc I. Znacilnosti populacije Doma starejših obcanov Bežigrad od 1977-1987. Zdrav Var 1991; 30: 75-78
17. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, et al. An outreach geriatric medication advisory service in residentialaged care: a randomised controlled trial of case conferencing. Age and Ageing 2004; 33: 612-617
18. Hosia-Randell HMV, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug-drug interaction in elderly nursing home residents in Helsinki, Finland. Drugs Aging 2008; 25: 683-692
19. Gallo JJ, Gonzales J. Depression and Other Mood Disorders. In: Adelman AM, Daly MP, Weiss BD, eds. 20 common problems in Geriatrics. New York: McGraw Hill; 2001. p. 205-235
20. Incalzi RA, Corsonello A, Pedone C, Corica F, Carbonin P. Depression and drug utilization in an elderly population. Ther Clin Risk Manag 2005; 1: 55-60.
21. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs. The relationships among dose, effectiveness, and side effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 234-264
22. Recept. Bilten o zdravilih iz obveznega zdravstvenega zavarovanja 2008; 6(2): 19-55.
23. Wrenger E, Muller R, Moesenthin M, Welte T, Frolich JC, Neumann KH. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. BMJ 2003; 327: 147-149
24. Boyd CM, Darer J, Boult C, Fried L, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid Diseases. JAMA 2005; 294: 716 24.